Cirrus ready for serialisation pack changes
Cirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending legislation. The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require many companies to apply serialisation codes to their packaging. As a consequence, artwork changes will be required which all too often are treated as a rushed after-thought.
Gill Wright, Design & Development Director, Cirrus, explained: “The World Health Organisation estimates that around 50% of product recalls are still attributed to artwork errors and mislabelling. It is essential that all brand-owners consider the required changes in good time. Pharmaceutical artwork is a specialist market and any supplier’s workflow should be compliant with PS9000 / ISO9001, audited and dedicated to providing an artwork service. Artwork creation is often complex and selecting the right partner prevents damaging hard-earned reputations, product recall…or even putting patient’s lives at risk.”
The impending legislation will affect many different products especially those sold in multiple markets. Gill continued: “The first step to comply with this legislation is to get your artwork amended and approved. It is essential you know that your artwork is in safe hands.”
About Multi Packaging Solutions
MPS is a leading global provider of value-added packaging solutions to a diverse customer base across the healthcare, consumer and multi-media markets. MPS provides its customers with an extensive array of print-based specialty packaging solutions, including premium folding cartons, inserts, labels and rigid packaging across a variety of substrates and finishes. MPS has over 60 manufacturing locations across North America, Europe and Asia and employs approximately 8,800 people.
Europe & Asia North America
Bob Houghton Cal Branagan
Marketing Communications Marketing Communications
+44 1635 290521 +1 (646) 834 1527